Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Guido Gembillo

Showing results (31-40 of 80) with videos related to

Pageof 8
Sort By:
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|February 11, 2025
Timing of the CKD Complications: A Longitudinal AnalysisVincenzo Calabrese, Guido Gembillo, Elisa Longhitano, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 3, 2025
Comparison Among Potassium Binders on the Management of Hyperkalemia on Chronic Dialysis Patients: A Protocol for Systematic ReviewVeronica Maressa, Alessandra Farina, Valeria Cernaro, et al.
International Journal of Molecular Sciences|June 2, 2021
Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical FactorsAnnalisa Giandalia, Alfio Edoardo Giuffrida, Guido Gembillo, et al.
Minerva Urology and Nephrology|September 11, 2025
Differences in efficacy and safety between HIF-PHIS and ESA/placebo in a sample of hemodialysis patients: a systematic review and meta-analysisValeria Cernaro, Veronica Maressa, Guido Gembillo, et al.
Expert Opinion on Investigational Drugs|March 2, 2024
Investigational new drugs for the treatment of chronic renal failure: an overview of the literatureChiara Terzo, Guido Gembillo, Valeria Cernaro, et al.
Expert Opinion on Pharmacotherapy|August 1, 2023
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failureValeria Cernaro, Elisa Longhitano, Vincenzo Calabrese, et al.
Nutrients|July 29, 2023
Phosphate Control in Peritoneal Dialysis Patients: Issues, Solutions, and Open QuestionsValeria Cernaro, Michela Calderone, Guido Gembillo, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 9, 2026
[Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits (PGNMID) Associated with Marginal Zone B-cell Lymphoma: A Case of MGRS in a Patient with Nephrotic Syndrome and Rapidly Progressive Renal Failure]Luca Visconti, Sebastiano Calimeri, Guido Gembillo, et al.
Expert Review of Clinical Pharmacology|March 18, 2022
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic reviewGuido Gembillo, Valeria Cernaro, Alfio Edoardo Giuffrida, et al.
Journal of Clinical Medicine|January 11, 2022
Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney DiseaseVincenzo Calabrese, Valeria Cernaro, Valeria Battaglia, et al.
Pageof 8

Showing results (31-40 of 80) with videos related to

Sort By:
Pageof 8
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|February 11, 2025
Timing of the CKD Complications: A Longitudinal AnalysisVincenzo Calabrese, Guido Gembillo, Elisa Longhitano, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|March 3, 2025
Comparison Among Potassium Binders on the Management of Hyperkalemia on Chronic Dialysis Patients: A Protocol for Systematic ReviewVeronica Maressa, Alessandra Farina, Valeria Cernaro, et al.
International Journal of Molecular Sciences|June 2, 2021
Gender Differences in Diabetic Kidney Disease: Focus on Hormonal, Genetic and Clinical FactorsAnnalisa Giandalia, Alfio Edoardo Giuffrida, Guido Gembillo, et al.
Minerva Urology and Nephrology|September 11, 2025
Differences in efficacy and safety between HIF-PHIS and ESA/placebo in a sample of hemodialysis patients: a systematic review and meta-analysisValeria Cernaro, Veronica Maressa, Guido Gembillo, et al.
Expert Opinion on Investigational Drugs|March 2, 2024
Investigational new drugs for the treatment of chronic renal failure: an overview of the literatureChiara Terzo, Guido Gembillo, Valeria Cernaro, et al.
Expert Opinion on Pharmacotherapy|August 1, 2023
Progress in pharmacotherapy for the treatment of hyperphosphatemia in renal failureValeria Cernaro, Elisa Longhitano, Vincenzo Calabrese, et al.
Nutrients|July 29, 2023
Phosphate Control in Peritoneal Dialysis Patients: Issues, Solutions, and Open QuestionsValeria Cernaro, Michela Calderone, Guido Gembillo, et al.
Giornale Italiano Di Nefrologia : Organo Ufficiale Della Societa Italiana Di Nefrologia|July 9, 2026
[Proliferative Glomerulonephritis with Monoclonal Immunoglobulin Deposits (PGNMID) Associated with Marginal Zone B-cell Lymphoma: A Case of MGRS in a Patient with Nephrotic Syndrome and Rapidly Progressive Renal Failure]Luca Visconti, Sebastiano Calimeri, Guido Gembillo, et al.
Expert Review of Clinical Pharmacology|March 18, 2022
Gender differences in new hypoglycemic drug effects on renal outcomes: a systematic reviewGuido Gembillo, Valeria Cernaro, Alfio Edoardo Giuffrida, et al.
Journal of Clinical Medicine|January 11, 2022
Correlation between Hyperkalemia and the Duration of Several Hospitalizations in Patients with Chronic Kidney DiseaseVincenzo Calabrese, Valeria Cernaro, Valeria Battaglia, et al.
Pageof 8